Cover Image
市場調查報告書

POC診斷 (照護現場診斷)的全球市場:2017年∼2021年

Global POC Diagnostics Market 2017-2021

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 325006
出版日期 內容資訊 英文 117 Pages
訂單完成後即時交付
價格
Back to Top
POC診斷 (照護現場診斷)的全球市場:2017年∼2021年 Global POC Diagnostics Market 2017-2021
出版日期: 2017年07月05日 內容資訊: 英文 117 Pages
簡介

全球POC診斷 (照護現場診斷) 市場預測從2017年到2021年間,將以7.95%的年複合成長率 (CAGR) 擴大。

本報告依產品,終端用戶及地區別提供全球POC診斷 (照護現場診斷) 市場現狀分析與今後預測,市場成長因素與課題,主要趨勢,主要供應商簡介等資訊。

第1章 摘要整理

第2章 本報告的調查範圍

第3章 調查手法

第4章 簡介

  • 市場概要

第5章 市場形勢

  • 市場概要
  • 市場規模與預測
  • 波特的五力分析

第6章 各產品的市場分類

  • 市場概要
  • 全球POC血糖值檢驗市場
  • 全球POC血紅素A1c (HbA1c) 檢驗市場
  • 全球POC即時心血管檢驗市場
  • 全球POC血氣及電解質市場
  • 全球POC傳染病檢查市場
  • 全球POC即時血液凝固檢查市場
  • 全球POC血液檢驗市場
  • 全球POC妊娠檢驗市場
  • 全球POC驗尿市場
  • 全球POC脂質檢驗市場
  • 全球POC藥物濫用檢測市場
  • 全球POC驗便市場

第7章 各終端用戶的市場分類

  • 市場概要
  • 醫院·診所
  • 臨床診斷實驗室
  • 居家照護
  • 全球POC診斷市場:各終端用戶的購買標準分析

第8章 地理區分

  • 市場概要
  • 南北美洲
  • 歐洲·中東·非洲地區
  • 亞太地區

第9章 決策架構

第10章 市場成長因素與課題

  • 市場成長因素
  • 市場課題

第11章 市場趨勢

第12章 業者情勢

  • 競爭情形

第13章 主要供應商分析

  • Alere
  • F. Hoffmann-La Roche
  • Siemens Healthineers
  • Danaher
  • 關注企業
  • 其他卓越供應商

第14章 附錄

  • 簡稱清單

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: IRTNTR13347

About POC Diagnostics

POC diagnostic tests help in reducing the time between diagnosis and treatment of a disease. These tests are either antibody-based or microbial particle-based. Healthcare professionals or nurses collect the testing samples from the patient, perform analysis, and record the result. These tests include enzyme-linked immunosorbent assay (ELISA), agglutination tests, and lateral flow immunochromatography. In 2016, the global POC diagnostics market held 13.09% of the global IVD market.

Technavio's analysts forecast the global POC diagnostics market to grow at a CAGR of 7.95% during the period 2017-2021.

Covered in this report

The report covers the present scenario and the growth prospects of the global POC diagnostics market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sales, volume and value of POC diagnostics.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA

Technavio's report, Global POC Diagnostics Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

  • Alere,
  • F. Hoffmann-La Roche,
  • Siemens Healthineers
  • Abbott
  • PTS Diagnostics
  • Danaher

Other Prominent Vendors

  • Accriva Diagnostics
  • Aesynt
  • CoaguSense
  • Diagon
  • DiaSys
  • EKF Diagnostics
  • Epistem
  • FUJIFILM
  • Helena Laboratories
  • HemoSonics
  • iLine Microsystems
  • Jant Pharmacal
  • LifeScan
  • Micropoint Bioscience
  • Nova Biomedical
  • Philips healthcare
  • PixCell
  • Quidel
  • Radisens Diagnostics
  • Securetec
  • Detektions-Systeme
  • Sysmex
  • TaiDoc

Market driver

  • Growing focus on diagnosing life-threatening conditions
  • For a full, detailed list, view our report

Market challenge

  • Lack of skilled professionals to carry out POC diagnosis
  • For a full, detailed list, view our report

Market trend

  • Emerging technology of molecular diagnosis in POC
  • For a full, detailed list, view our report

Key questions answered in this report

  • What will the market size be in 2021 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Table of Contents

PART 01: Executive summary

PART 02: Scope of the report

PART 03: Research Methodology

PART 04: Introduction

  • Market outline

PART 05: Market landscape

  • Market overview
  • Market size and forecast
  • Five forces analysis

PART 06: Market segmentation by product

  • Market overview
  • Global POC blood glucose diagnostics market
  • Global POC HbA1c diagnostics market
  • Global POC rapid cardiovascular diagnostics market
  • Global POC blood gas and electrolyte diagnostics market
  • Global POC infectious disease diagnostics market
  • Global POC rapid coagulation diagnostics market
  • Global POC Hematology diagnostics market
  • Global POC pregnancy diagnostics market
  • Global POC urinalysis market
  • Global POC lipid testing market
  • Global POC drug of abuse diagnostics market
  • Global POC fecal occult testing market

PART 07: Market segmentation by end-user

  • Market overview
  • Hospitals and clinics
  • Clinical diagnostic laboratories
  • Home care settings
  • Buying criteria analysis: Global POC Diagnostics market by end-users 2016

PART 08: Geographical segmentation

  • Market overview
  • Global POC diagnostic market in Americas
  • Global POC diagnostic market in EMEA
  • Global POC diagnostic market in APAC

PART 09: Decision framework

PART 10: Drivers and challenges

  • Market drivers
  • Market challenges

PART 11: Market trends

  • Focus on next-generation technologies
  • Increasing online marketing services for POC diagnosis
  • Data management and connectivity to EHRs through interoperability

PART 12: Vendor landscape

  • Competitive landscape

PART 13: Key vendor analysis

  • Alere
  • F. Hoffmann-La Roche
  • Siemens Healthineers
  • Danaher
  • Key companies to watch
  • Other prominent vendors

PART 14: Appendix

  • List of abbreviations

List of Exhibits

  • Exhibit 01: Market overview of global IVD and POC diagnostics market 2016
  • Exhibit 02: Market outline of global POC diagnostics market 2016
  • Exhibit 03: Global POC diagnostics market ($ millions)
  • Exhibit 04: Five forces analysis
  • Exhibit 05: Segment life cycle of POC diagnostics market in 2016
  • Exhibit 06: POC diagnostic market segmentation by product
  • Exhibit 07: Global POC diagnostics blood glucose market 2016-2021 ($ millions)
  • Exhibit 08: Market metric analysis: POC blood glucose diagnostics market 2016
  • Exhibit 09: Global POC HbA1c diagnostics market 2016-2021 ($ millions)
  • Exhibit 10: Market metric analysis: POC HbA1c diagnostics market 2016
  • Exhibit 11: Global POC rapid cardiovascular diagnostics market 2016-2021 ($ millions)
  • Exhibit 12: Market metric analysis: Global POC rapid cardiovascular diagnostics market 2016
  • Exhibit 13: Global POC blood gas and electrolyte diagnostics market 2016-2021 ($ millions)
  • Exhibit 14: Market metric analysis: Global POC blood gas and electrolyte diagnostics market 2016
  • Exhibit 15: Global POC infectious disease diagnostics market 2016-2021 ($ millions)
  • Exhibit 16: Increased prevalence of Hepatitis in US 2015
  • Exhibit 17: Market metric analysis: Global POC infectious disease diagnostics market 2016
  • Exhibit 18: Global POC rapid coagulation diagnostics market 2016-2021 ($ millions)
  • Exhibit 19: Market metric analysis: Global POC rapid coagulation diagnostics market 2016
  • Exhibit 20: Global POC hematology diagnostics market 2016-2021 ($ millions)
  • Exhibit 21: Market metric analysis: Global POC hematology diagnostics market 2016
  • Exhibit 22: Global POC pregnancy diagnostics market 2016-2021 ($ millions)
  • Exhibit 23: Market metric analysis: Global POC pregnancy diagnostics market 2016
  • Exhibit 24: Global POC urinalysis market 2016-2021 ($ millions)
  • Exhibit 25: Market metric analysis: Global POC urinalysis market 2016
  • Exhibit 26: Global POC lipid testing market 2016-2021 ($ millions)
  • Exhibit 27: Market metric analysis: Global POC lipid testing market 2016
  • Exhibit 28: Global POC drug of abuse diagnostics market 2016-2021 ($ millions)
  • Exhibit 29: Market metric analysis: Global POC drug of abuse diagnostics market 2016
  • Exhibit 30: Global POC fecal occult testing market 2016-2021 ($ millions)
  • Exhibit 31: Market metric analysis: Global POC fecal occult testing market 2016
  • Exhibit 32: Global POC diagnostic market segmentation by end-users 2016
  • Exhibit 33: Marketing strategy analysis of global POC diagnostics market by end-users 2016
  • Exhibit 34: Market overview by hospitals and clinics 2016
  • Exhibit 35: Market overview by clinical diagnostic laboratories 2016
  • Exhibit 36: Market overview by home care settings 2016
  • Exhibit 37: Global POC diagnostics market segmentation by geography 2016 and 2021 ($ millions)
  • Exhibit 38: Market overview: POC diagnostics market in Americas 2016-2021
  • Exhibit 39: Global POC diagnostics market in Americas ($ millions)
  • Exhibit 40: The Americas: Market metrics in various countries
  • Exhibit 41: Market overview: POC diagnostics market in EMEA (2016-2021)
  • Exhibit 42: Global POC diagnostics market in EMEA ($ millions)
  • Exhibit 43: Market overview: POC diagnostics market in APAC 2016-2021
  • Exhibit 44: Global POC diagnostics market in APAC ($ millions)
  • Exhibit 45: Global increasing percentage of older adult population 2015-2030
  • Exhibit 28: Favorable reimbursements by Abbott's cartridge in POCT for end-users in US
  • Exhibit 46: Complete list of products recalled by Alere in 2016
  • Exhibit 47: Competitive structure analysis of global POC diagnostics market 2016
  • Exhibit 48: Market penetration of various global POC diagnostic market providers 2017
  • Exhibit 49: Strategic success factors of companies in global POC diagnostic market 2017
  • Exhibit 50: Alere: Strength assessment
  • Exhibit 51: Alere: Strategy assessment
  • Exhibit 52: Alere: Opportunity assessment
  • Exhibit 53: F. Hoffmann-La Roche: Strength assessment
  • Exhibit 54: F. Hoffmann-La Roche: Strategy assessment
  • Exhibit 55: F. Hoffmann-La Roche: Opportunity assessment
  • Exhibit 56: Siemens Healthineers: Strength assessment
  • Exhibit 57: Siemens Healthineers: Strategy assessment
  • Exhibit 58: Siemens Healthineers: Opportunity assessment
  • Exhibit 59: Danaher: Key highlights
  • Exhibit 60: Danaher: Strength assessment
  • Exhibit 61: Danaher: Strategy assessment
  • Exhibit 62: Danaher: Opportunity assessment
  • Exhibit 63: Abbott: Company assessment
  • Exhibit 64: PTS diagnostics: Company assessment
Back to Top